PerpEquities

Equity

Revolution Medicines, Inc. (RVMD) perpetual futures

Revolution Medicines, Inc. is a clinical-stage precision oncology company developing targeted therapies for RAS-driven cancers, including RAS(ON) inhibitors and SHP2 inhibitors.

-6.0%NASDAQ closed
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NASDAQ:RVMD

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

0/1 live markets
Venues
1
Live markets
0/1
24h volume
-
Open interest
-
Best liquidity
-
Tightest spread
-
Highest volume
-
Settlement mix
USDT · 1/1
Perp/spot vol.
-
OI / float
-
Spot performance
1D-5.97%
5D-5.23%
1M-9.64%
6M+19.73%
YTD+123.43%
1Y+228.95%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeRVMD-USDTWatchlist------USDT-
Best venues for this underlying

Best liquidity

-
No live data-

Tightest spread

-
No live data-

Highest volume

-
No live data-

Company data

Company fundamentals

Updated 2h ago
Market cap
$38.1B
Updated 2h ago
Revenue
$0
Trailing 12 months
Revenue growth
+637%
Next fiscal year
Profit margin
0.0%
P/E
-20.1
Peer P/E 31.9
Free cash flow
-$1.2B
Trailing 12 months
More metrics
Net income
-$1.8B
Trailing 12 months
P/S
-
Peer P/E
31.9
Similar listed perps
Revenue estimate
$197.2M
Next fiscal year
Earnings
2026-11-04
Revenue est. $23.7M · Updated 2h ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$0
Net margin0.0%
Free cash flow-$913.7M
Net debt-$225M
2020$43M
2021$29.4M
2022$35.4M
2023$11.6M
2024$0
2025$0
PeriodRevenueGrowthNet incomeFCF
2020$43M-14%-$108.2M-$103M
2021$29.4M-32%-$187.1M-$153.7M
2022$35.4M+20%-$248.7M-$235.2M
2023$11.6M-67%-$436.4M-$358.3M
2024$0-100%-$600.1M-$567.7M
2025$0--$1.1B-$913.7M
PeriodGross marginOperating marginNet marginROEROA
2020+100.0%-257.5%-251.6%-22.8%-19.1%
2021+100.0%-639.7%-636.6%-31.0%-25.4%
2022+100.0%-730.0%-703.0%-36.3%-30.6%
2023+100.0%-4,207.1%-3,768.3%-23.9%-21.2%
20240.0%0.0%0.0%-26.5%-23.5%
20250.0%0.0%0.0%-69.3%-48.0%
PeriodCashDebtNet debtCurrent ratio
2020$104.3M$32.7M-$71.6M9.63
2021$108.5M$66.6M-$41.9M9.77
2022$161.4M$64.2M-$97.2M10.65
2023$696.1M$87.9M-$608.2M13.06
2024$543.1M$135.8M-$407.2M14.20
2025$383.7M$158.7M-$225M7.14
PeriodMarket capEnterprise valueP/SP/E
2020$2.6B$2.6B61.3-24.4
2021$1.8B$1.8B62.4-10.2
2022$1.9B$1.8B54.3-7.7
2023$3.2B$2.6B280.2-7.4
2024$7.3B$6.9B0.0-12.2
2025$15.1B$14.9B0.0-13.4
Q3 2024$0
Q4 2024$0
Q1 2025$0
Q2 2025$0
Q3 2025$0
Q4 2025$0
Q1 2026$0
Q2 2026$0
PeriodRevenueGrowthNet incomeFCF
Q3 2024$0--$156.3M-$133.9M
Q4 2024$0-100%-$194.6M-$139.5M
Q1 2025$0--$213.4M-$197.7M
Q2 2025$0--$247.8M-$229.2M
Q3 2025$0--$305.2M-$210.7M
Q4 2025$0--$364.9M-$276.2M
Q1 2026$0--$453.8M-$355.7M
Q2 2026$0--$644.4M-$389.6M
PeriodGross marginOperating marginNet marginROEROA
Q3 20240.0%0.0%0.0%-10.0%-8.9%
Q4 20240.0%0.0%0.0%-8.6%-7.6%
Q1 20250.0%0.0%0.0%-10.3%-9.0%
Q2 20250.0%0.0%0.0%-13.3%-10.2%
Q3 20250.0%0.0%0.0%-19.1%-13.6%
Q4 20250.0%0.0%0.0%-22.4%-15.5%
Q1 20260.0%0.0%0.0%-30.3%-20.1%
Q2 20260.0%0.0%0.0%-24.7%-14.9%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$201.3M$86.7M-$114.6M14.24
Q4 2024$543.1M$135.8M-$407.2M14.20
Q1 2025$333.6M$134.3M-$199.2M13.46
Q2 2025$402.4M$132.8M-$269.7M11.79
Q3 2025$217.4M$158.5M-$59M8.05
Q4 2025$383.7M$158.7M-$225M7.14
Q1 2026$440.9M$437.3M-$3.7M6.80
Q2 2026$815.4M$641.9M-$173.5M11.38
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$7.6B$7.5B0.0-12.1
Q4 2024$7.3B$6.9B0.0-9.7
Q1 2025$6.7B$6.5B0.0-7.8
Q2 2025$6.9B$6.7B0.0-7.0
Q3 2025$8.8B$8.8B0.0-7.3
Q4 2025$15.1B$14.9B0.0-10.5
Q1 2026$19.3B$19.3B0.0-10.6
Q2 2026$39.5B$39.3B0.0-15.3

Refreshed 2h ago

Charts: revenue, profit, cash flow & valuation
Revenue$0Q2 2026
$185.5K$371K$556.5K$742KQ3 2023: $0Q4 2023: $742KQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0Q3 2023Q2 2026
Net income-$644.4MQ2 2026
-$483.3M-$322.2M-$161.1MQ3 2023: -$108.4MQ4 2023: -$161.5MQ1 2024: -$116MQ2 2024: -$133.2MQ3 2024: -$156.3MQ4 2024: -$194.6MQ1 2025: -$213.4MQ2 2025: -$247.8MQ3 2025: -$305.2MQ4 2025: -$364.9MQ1 2026: -$453.8MQ2 2026: -$644.4MQ3 2023Q2 2026
EBITDA-$616.1MQ2 2026
-$462.1M-$308M-$154MQ3 2023: -$110.2MQ4 2023: -$129.5MQ1 2024: -$113.2MQ2 2024: -$130.4MQ3 2024: -$153.4MQ4 2024: -$191.9MQ1 2025: -$209.7MQ2 2025: -$244MQ3 2025: -$289.4MQ4 2025: -$348.3MQ1 2026: -$437.1MQ2 2026: -$616.1MQ3 2023Q2 2026
Free cash flow-$389.6MQ2 2026
-$292.2M-$194.8M-$97.4MQ3 2023: -$103MQ4 2023: -$122.9MQ1 2024: -$163.7MQ2 2024: -$130.6MQ3 2024: -$133.9MQ4 2024: -$139.5MQ1 2025: -$197.7MQ2 2025: -$229.2MQ3 2025: -$210.7MQ4 2025: -$276.2MQ1 2026: -$355.7MQ2 2026: -$389.6MQ3 2023Q2 2026
EPS-$3.06Q2 2026
-$2.3-$1.53-$0.77Q3 2023: -$0.99Q4 2023: -$1.14Q1 2024: -$0.7Q2 2024: -$0.81Q3 2024: -$0.94Q4 2024: -$1.13Q1 2025: -$1.13Q2 2025: -$1.31Q3 2025: -$1.61Q4 2025: -$1.9Q1 2026: -$2.29Q2 2026: -$3.06Q3 2023Q2 2026
Cash / Debt$815.4MQ2 2026
$203.9M$407.7M$611.6M$815.4MQ3 2023 · Cash: $358.4MQ3 2023 · Debt: $62.8MQ4 2023 · Cash: $696.1MQ4 2023 · Debt: $87.9MQ1 2024 · Cash: $288.4MQ1 2024 · Debt: $88MQ2 2024 · Cash: $275.7MQ2 2024 · Debt: $87.4MQ3 2024 · Cash: $201.3MQ3 2024 · Debt: $86.7MQ4 2024 · Cash: $543.1MQ4 2024 · Debt: $135.8MQ1 2025 · Cash: $333.6MQ1 2025 · Debt: $134.3MQ2 2025 · Cash: $402.4MQ2 2025 · Debt: $132.8MQ3 2025 · Cash: $217.4MQ3 2025 · Debt: $158.5MQ4 2025 · Cash: $383.7MQ4 2025 · Debt: $158.7MQ1 2026 · Cash: $440.9MQ1 2026 · Debt: $437.3MQ2 2026 · Cash: $815.4MQ2 2026 · Debt: $641.9MQ3 2023Q2 2026
CashDebt
Profitability0.0%Q2 2026
-18,167.4%-12,078.2%-5,989.1%+100.0%Q3 2023 · Gross margin: 0.0%Q4 2023 · Gross margin: +100.0%Q1 2024 · Gross margin: 0.0%Q2 2024 · Gross margin: 0.0%Q3 2024 · Gross margin: 0.0%Q4 2024 · Gross margin: 0.0%Q1 2025 · Gross margin: 0.0%Q2 2025 · Gross margin: 0.0%Q3 2025 · Gross margin: 0.0%Q4 2025 · Gross margin: 0.0%Q1 2026 · Gross margin: 0.0%Q2 2026 · Gross margin: 0.0%Q3 2023 · Operating margin: 0.0%Q4 2023 · Operating margin: -24,256.5%Q1 2024 · Operating margin: 0.0%Q2 2024 · Operating margin: 0.0%Q3 2024 · Operating margin: 0.0%Q4 2024 · Operating margin: 0.0%Q1 2025 · Operating margin: 0.0%Q2 2025 · Operating margin: 0.0%Q3 2025 · Operating margin: 0.0%Q4 2025 · Operating margin: 0.0%Q1 2026 · Operating margin: 0.0%Q2 2026 · Operating margin: 0.0%Q3 2023 · Net margin: 0.0%Q4 2023 · Net margin: -21,770.5%Q1 2024 · Net margin: 0.0%Q2 2024 · Net margin: 0.0%Q3 2024 · Net margin: 0.0%Q4 2024 · Net margin: 0.0%Q1 2025 · Net margin: 0.0%Q2 2025 · Net margin: 0.0%Q3 2025 · Net margin: 0.0%Q4 2025 · Net margin: 0.0%Q1 2026 · Net margin: 0.0%Q2 2026 · Net margin: 0.0%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth-100.0%Q4 2024
-75.0%-50.0%-25.0%Q4 2024: -100.0%Q3 2023Q2 2026
Shares outstanding210.9MQ2 2026
52.7M105.4M158.2M210.9MQ3 2023: 109.2MQ4 2023: 141.2MQ1 2024: 164.7MQ2 2024: 165.1MQ3 2024: 166.8MQ4 2024: 167.7MQ1 2025: 188.1MQ2 2025: 188.1MQ3 2025: 189.2MQ4 2025: 190.1MQ1 2026: 198.1MQ2 2026: 210.9MQ3 2023Q2 2026
Valuation-15.3Q2 2026
1,352.82,720.94,089.05,457.1Q3 2023 · P/E: -7.0Q4 2023 · P/E: -6.3Q1 2024 · P/E: -11.3Q2 2024 · P/E: -12.0Q3 2024 · P/E: -12.1Q4 2024 · P/E: -9.7Q1 2025 · P/E: -7.8Q2 2025 · P/E: -7.0Q3 2025 · P/E: -7.3Q4 2025 · P/E: -10.5Q1 2026 · P/E: -10.6Q2 2026 · P/E: -15.3Q3 2023 · P/S: 0.0Q4 2023 · P/S: 5,457.1Q1 2024 · P/S: 0.0Q2 2024 · P/S: 0.0Q3 2024 · P/S: 0.0Q4 2024 · P/S: 0.0Q1 2025 · P/S: 0.0Q2 2025 · P/S: 0.0Q3 2025 · P/S: 0.0Q4 2025 · P/S: 0.0Q1 2026 · P/S: 0.0Q2 2026 · P/S: 0.0Q3 2023Q2 2026
P/EP/S
Revenue$02025
$12.5M$25M$37.5M$50M2018: $20.2M2019: $50M2020: $43M2021: $29.4M2022: $35.4M2023: $11.6M2024: $02025: $020182025
Net income-$1.1B2025
-$848.5M-$565.7M-$282.8M2018: -$41.8M2019: -$47.7M2020: -$108.2M2021: -$187.1M2022: -$248.7M2023: -$436.4M2024: -$600.1M2025: -$1.1B20182025
EBITDA-$1.1B2025
-$817.9M-$545.3M-$272.6M2018: -$39.9M2019: -$48.6M2020: -$101.9M2021: -$179.7M2022: -$239.5M2023: -$430.3M2024: -$589M2025: -$1.1B20182025
Free cash flow-$913.7M2025
-$685.3M-$456.9M-$228.4M2018: -$286K2019: -$52.2M2020: -$103M2021: -$153.7M2022: -$235.2M2023: -$358.3M2024: -$567.7M2025: -$913.7M20182025
EPS-$5.952025
-$4.46-$2.98-$1.492018: -$1.152019: -$1.312020: -$1.622021: -$2.472022: -$3.082023: -$3.862024: -$3.582025: -$5.9520182025
Cash / Debt$383.7M2025
$174M$348.1M$522.1M$696.1M2018 · Cash: $69.6M2018 · Debt: $147K2019 · Cash: $16.7M2019 · Debt: $02020 · Cash: $104.3M2020 · Debt: $32.7M2021 · Cash: $108.5M2021 · Debt: $66.6M2022 · Cash: $161.4M2022 · Debt: $64.2M2023 · Cash: $696.1M2023 · Debt: $87.9M2024 · Cash: $543.1M2024 · Debt: $135.8M2025 · Cash: $383.7M2025 · Debt: $158.7M20182025
CashDebt
Profitability0.0%2025
-3,130.3%-2,053.6%-976.8%+100.0%2018 · Gross margin: +100.0%2019 · Gross margin: +100.0%2020 · Gross margin: +100.0%2021 · Gross margin: +100.0%2022 · Gross margin: +100.0%2023 · Gross margin: +100.0%2024 · Gross margin: 0.0%2025 · Gross margin: 0.0%2018 · Operating margin: -200.0%2019 · Operating margin: -108.2%2020 · Operating margin: -257.5%2021 · Operating margin: -639.7%2022 · Operating margin: -730.0%2023 · Operating margin: -4,207.1%2024 · Operating margin: 0.0%2025 · Operating margin: 0.0%2018 · Net margin: -207.2%2019 · Net margin: -95.2%2020 · Net margin: -251.6%2021 · Net margin: -636.6%2022 · Net margin: -703.0%2023 · Net margin: -3,768.3%2024 · Net margin: 0.0%2025 · Net margin: 0.0%20182025
Gross marginOperating marginNet margin
Revenue growth-100.0%2024
-38.0%+24.1%+86.1%+148.2%2019: +148.2%2020: -14.1%2021: -31.6%2022: +20.4%2023: -67.3%2024: -100.0%20182025
Shares outstanding190.1M2025
47.5M95.1M142.6M190.1M2018: 36.5M2019: 36.5M2020: 66.6M2021: 72.8M2022: 80.6M2023: 113.1M2024: 167.7M2025: 190.1M20182025
Valuation-13.42025
51.2127.6203.9280.22018 · P/E: -25.12019 · P/E: -22.12020 · P/E: -24.42021 · P/E: -10.22022 · P/E: -7.72023 · P/E: -7.42024 · P/E: -12.22025 · P/E: -13.42018 · P/S: 52.32019 · P/S: 21.12020 · P/S: 61.32021 · P/S: 62.42022 · P/S: 54.32023 · P/S: 280.22024 · P/S: 0.02025 · P/S: 0.020182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-11-04
Revenue est. $23.7M · Updated 2h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 2026-9.49$197.2M-19
FY 2027-5.88$1.2B-19
FY 2028-2.64$2.4B-18
FY 20295.09$4.6B-9
FY 203013.58$7.5B-8
Q1 2027-1.78$232.6M-8

Company events

6
2026-11-04EarningsActual - / Estimate -2.34-
2026-08-05EarningsActual -3.06 / Estimate -2.04Miss
2026-05-06EarningsActual -2.29 / Estimate -1.84Miss
2026-02-25EarningsActual -1.86 / Estimate -1.58Miss
2025-11-05EarningsActual -1.61 / Estimate -1.42Miss
2025-08-06EarningsActual -1.31 / Estimate -1.14Miss

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
RKLB$38B49.5-237.3-21.5%24CLS$38.3B2.531.3+7.2%2KR$38.3B0.333.5+0.7%1EL$37.9B2.5205.0+1.2%1CMG$37.8B3.027.4+11.4%2OKTA$37.7B12.3134.4+9.6%8TTWO$37.6B5.6-116.3-4.8%18TWLO$37.5B6.732.5+20.6%9

Analyst track record

How the analysts covering RVMD have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings237429
Analysts3237
Buy / hold / sell232 / 5 / 0423 / 6 / 0
Upgrades / downgrades / initiations0 / 1 / 111 / 1 / 22
Price targets hit / missed124 / 84 (60%)290 / 84 (78%)
Avg. return after a rating (TipRanks)+24.9%+116.3%
Best / worst call+186.8% / -40.9%+627.9% / -40.9%

After buy calls on this stock: median 21-day move +2.7% vs S&P 500 +0.6% (n = 414)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Jay OlsonOppenheimer100% hit rate on this stock · 13 targets measuredBuytarget $260Aug 27, 2026
  2. Peter LawsonBarclays94% hit rate on this stock · 17 targets measuredBuytarget $72.00Oct 23, 2025
  3. Robert BurnsH.C. Wainwright93% hit rate on this stock · 15 targets measuredBuytarget $280Aug 27, 2026

Latest ratings

DateAnalystCallTarget
Oct 15, 2026Unknown AnalystWilliam BlairBuyInitiated$226article ↗
Oct 15, 2026Unknown AnalystWilliam BlairBuyInitiated–article ↗
Oct 15, 2026Ami FadiaNeedhamBuyReiterated$275article ↗
Oct 15, 2026Ami FadiaNeedhamBuyReiterated$275
Oct 14, 2026Leonid TimashevRBC CapitalBuyMaintained$260article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$80.00$100$120$140$160$180$200$220$240Nov 25 · Buy 19 · Hold 0 · Sell 0Nov 25Dec 25 · Buy 19 · Hold 0 · Sell 0Jan 26 · Buy 19 · Hold 0 · Sell 0Jan 26Feb 26 · Buy 21 · Hold 0 · Sell 0Mar 26 · Buy 22 · Hold 0 · Sell 0Mar 26Apr 26 · Buy 21 · Hold 0 · Sell 0May 26 · Buy 23 · Hold 1 · Sell 0May 26Jun 26 · Buy 23 · Hold 2 · Sell 0Jul 26 · Buy 23 · Hold 2 · Sell 0Jul 26Aug 26 · Buy 23 · Hold 2 · Sell 0Sep 26 · Buy 25 · Hold 2 · Sell 0Sep 26Oct 26 · Buy 26 · Hold 2 · Sell 0Nov 25 · avg. target $77.44Dec 25 · avg. target $79.11Jan 26 · avg. target $113Feb 26 · avg. target $126Mar 26 · avg. target $126Apr 26 · avg. target $170May 26 · avg. target $173Jun 26 · avg. target $184Jul 26 · avg. target $189Aug 26 · avg. target $237Sep 26 · avg. target $244Oct 26 · avg. target $248Nov 25 · month-end close $77.76Dec 25 · month-end close $79.65Jan 26 · month-end close $96.95Feb 26 · month-end close $102Mar 26 · month-end close $97.25Apr 26 · month-end close $144May 26 · month-end close $157Jun 26 · month-end close $187Jul 26 · month-end close $188Aug 26 · month-end close $206Sep 26 · month-end close $205Oct 26 · month-end close $178

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Oct 16, 2026 · 237 ratings

Embed this asset

RVMD perpetuals · perpequities.comRVMD perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/rvmd-perp"><img src="https://perpequities.com/badge/rvmd-perp.svg" width="240" height="64" alt="RVMD perpetuals · perpequities.com" loading="lazy"></a>

Raw data: JSON · CSV · API

Next step

Stay on top of RVMD perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for RVMD — one email every Sunday.

Watchlist and alerts

Price and funding alerts for RVMD, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X